The precisionFDA team has launched the fourth precisionFDA challenge to continue its support of the genomics community in assessing, comparing, and improving techniques used for Next Generation Sequencing (NGS) analysis.
This challenge will provide a unique opportunity for test developers to investigate the accuracy of their pipelines by testing the ability to find in silico injected variants in FASTQ files from exome sequencing of reference cell lines. It will be a warm up for the community ahead of a more difficult in silico challenge to come in the fall.
The challenge runs until September 12, 2017. To learn more visit: https://precision.fda.gov/challenges/